Sebastian Giebel

Gliwice Branch
Gliwice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 247 publications

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Journal: Bone marrow transplantation

Published: August 31, 2026

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.

Journal: The Lancet. Haematology

Published: April 25, 2026

Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial).

Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial).

Journal: Annals of hematology

Published: April 19, 2026

Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities.

Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities.

Journal: Bone marrow transplantation

Published: April 05, 2026

Trajectories of anxiety and depressive symptoms during hospitalization for hematopoietic stem cell transplantation.

Trajectories of anxiety and depressive symptoms during hospitalization for hematopoietic stem cell transplantation.

Journal: Scientific reports

Published: April 03, 2026

Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT.

Journal: Bone marrow transplantation

Published: March 15, 2026

Long-term outcomes of allogeneic hematopoietic stem cell transplantation in adult philadelphia chromosome-positive all treated with tyrosine kinase inhibitors in the pre-blinatumumab era. A retrospective analysis on behalf of the polish adult leukemia group.

Long-term outcomes of allogeneic hematopoietic stem cell transplantation in adult philadelphia chromosome-positive all treated with tyrosine kinase inhibitors in the pre-blinatumumab era. A retrospective analysis on behalf of the polish adult leukemia group.

Journal: Leukemia research

Published: March 06, 2026

NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation.

NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation.

Journal: Archivum immunologiae et therapiae experimentalis

Published: January 07, 2026

Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party.

Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party.

Journal: Bone marrow transplantation

Published: October 03, 2025

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.

Journal: Annals of hematology

Published: September 20, 2025

Safe in transit: HSCT clinical outcomes unaffected by stem cell transport time.

Safe in transit: HSCT clinical outcomes unaffected by stem cell transport time.

Journal: Bone marrow transplantation

Published: August 26, 2025

Impact of MICA-129 Mismatch on Hematopoietic Stem Cell Transplantation Outcomes: Evidence from a Large European Cohort and Meta-Analysis.

Impact of MICA-129 Mismatch on Hematopoietic Stem Cell Transplantation Outcomes: Evidence from a Large European Cohort and Meta-Analysis.

Journal: Transplantation and cellular therapy

Published: August 26, 2025

Showing 1-12 of 247

Last Updated: 09/26/2026